Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07284277 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)

StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The purpose of this clinical trial is to assess the safety and tolerability of TTFields in combination with chemotherapy in adults with metastatic pancreatic adenocarcinoma based on treatment-emergent adverse events of chemotherapy (modFOLFIRINOX) or device (TTFields). The main questions it aims to answer are: * Is TTFields treatment safe for the patients in combination with modFOLFIRINOX? * Are participants compliant with the treatment? * Is Is TTFields treatment effective in combination with modFOLFIRINOX against metastatic pancreatic adenocarcinoma?
Trial Details
NCT Number NCT07284277
Lead Sponsor Clinica Universidad de Navarra, Universidad de Navarra
Conditions
(from sponsor)		 Pancreatic Adenocarcinoma Metastatic, Pancreatic Ductal Adenocarcinoma
Related terms Pancreatic Neoplasms
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov